Morning Briefing
Summaries of health policy coverage from major news organizations
Research Roundup: The Latest Science, Discoveries, And Breakthroughs
Higher fish consumption was tied to less disability progression among people with multiple sclerosis (MS), a case-control study in Sweden showed. (George, 2/26)
Risk of suicidality wasn't higher for type 2 diabetes patients starting on GLP-1 receptor agonists than for those on two other popular classes of diabetes drugs, a U.K. cohort study found. (Monaco, 2/26)
Extracorporeal membrane oxygenation, or ECMO, is one of the most serious life support measures offered at a hospital, with critically ill patients often receiving both heart and lung support for a number of days or weeks during organ and respiratory failure. (Soucheray, 2/25)
A study conducted among hospitalized children in Ohio shows that rates of macrolide-resistant Mycoplasma pneumoniae (MRMp) are low but have been rising in the wake of the COVID-19 pandemic, researchers reported last week in Emerging Infectious Diseases. (Dall, 2/24)
For children and teens living with migraine, there may be a new preventive treatment, according to a preliminary study. Researchers found the drug zonisamide, which has been used to treat seizures, may reduce migraine days in this age group. This study does not prove that zonisamide reduces migraine days; it only shows an association. (American Academy of Neurology, 2/26)
A research study has analyzed the relation between the genetic risk of having schizophrenia and mild subclinical traits in people of the general population. According to the study, the way the genetic risk of having this disorder affects these subclinical traits is different in men and women. (Universitat Autonoma de Barcelona, 2/26)